Table of Contents
How to Start a Sterilizers and Disinfectants Trading Business with Meydan Free Zone
Introduction
The global market for sterilizers and disinfectants is one of the most resilient and consistently growing segments of the healthcare supply chain, underpinned by non-negotiable infection control standards, expanding healthcare infrastructure, and a growing pharmaceutical manufacturing base worldwide. According to The Business Research Company¹, the sterilization equipment and disinfectants market was valued at USD 6.98 billion in 2024 and is projected to reach USD 10.81 billion by 2029, growing at a CAGR of 8.9%.
The high-level disinfectants and terminal sterilization segment is growing even faster, valued at USD 14.63 billion in 2024 and forecast to reach USD 26.43 billion by 2030 at a CAGR of 10.2%, according to Research and Markets².
Growth is driven by the rising burden of hospital-acquired infections, increasing numbers of surgical procedures globally, tightening pharmaceutical cleanroom standards, and growing demand for eco-friendly disinfectant formulations. The Ministry of Health and Prevention (MOHAP)³ has identified hospital-acquired infections as a key national health challenge, with infection control and sterilisation protocols mandated across all licensed healthcare facilities in the UAE under the regulatory frameworks of MOHAP, the Dubai Health Authority (DHA), and the Department of Health Abu Dhabi.
The UAE’s pharmaceutical sector adds a further demand layer. According to IMARC Group⁴, the UAE pharmaceutical market was valued at USD 4.15 billion in 2024 and is projected to reach USD 8.02 billion by 2033 at a CAGR of 7.3%, with significant growth in local sterile manufacturing.
The sector now operates 23 local manufacturing centres, with new sterile injectable and antibiotic facilities coming online, each requiring validated pharmaceutical-grade disinfectants and sterilants as core operational inputs.
For traders in sterilizers and disinfectants, the UAE’s combination of a rapidly expanding healthcare estate, mandatory infection control regulation, a growing pharmaceutical manufacturing base, and a food-sector governed by Dubai Municipality’s Food Code creates a deep, multi-sector procurement pipeline that is both durable and regulation-driven.
Market at a glance
4773 — Retail sale of other new goods in specialised stores
Activity code 4773.e8 falls within ISIC class 4773, which covers the retail sale of new goods across a range of specialised product categories. Within this class, sub-code 4773.e8 is specifically designated for Sterilizers and Disinfectants Trading — the retail sale of sterilisers, sterilisation equipment, chemical disinfectants, liquid sterilants, antiseptics, and sterilisation consumables used across healthcare, pharmaceutical, laboratory, food-processing, and institutional settings.
Businesses operating under this code are authorised to source and sell such products to end customers through a specialised commercial channel.
What this activity does not cover
Licensing and compliance
Who is this for?
| Audience Segment | Profile |
|---|---|
| Sterilization equipment & disinfectants (2024) | $6.98B Global market size |
| Projected market size (2029) | $10.81B CAGR 8.9% (2024–2029) |
| High-level disinfectants market (2024) | $14.63B CAGR 10.2% to 2030 |
Activity Details
Healthcare product traders Businesses supplying chemical disinfectants, sterilising agents, and autoclave products to hospitals, surgical centres, clinics, and dental practices in the UAE’s rapidly expanding healthcare sector.
Pharma & lab suppliersCompanies sourcing and distributing sterile disinfectant products, reagents, and sterilisation consumables to pharmaceutical manufacturers, biotechnology firms, and laboratory operators in the UAE and wider GCC.
Institutional & food-sector distributorsTraders supplying food-grade disinfectants, surface sterilisers, and sanitation chemicals to food processing facilities, hospitality operators, and institutional clients governed by Dubai Municipality and MOHAP hygiene standards.
| Category | Scope |
|---|---|
| UAE pharmaceutical market | $4.15B UAE pharmaceutical market value (2024) Pharma market CAGR (2025–2033) 7.3% Projected pharma market (2033) $8.02B Sterilization market proj. (2033) $26.5B |
| Key end-use sectors | Hospitals & surgical centres — Dominant Pharmaceutical manufacturing — Fast growing Dental & outpatient clinics — Regulated Food & beverage processing — Growing Labs & research facilities — Expanding |
